How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Neuromuscular blocking agents (NMBAs) have been shown to improve the outcome of the most severely hypoxemic, acute respiratory distress syndrome (ARDS) patients. However, the recommended dosage as well as the necessity of monitoring the neuromuscular block is unknown. We aimed to evaluate the efficiency of a nurse-directed protocol of...
Alternative Titles
Full title
How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_fdd2ae4634334a4091cdd13436216bf8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fdd2ae4634334a4091cdd13436216bf8
Other Identifiers
ISSN
2110-5820
E-ISSN
2110-5820
DOI
10.1186/s13613-017-0305-2
